Uveitis Terminated Phase 3 Trials for Secukinumab (DB09029)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01095250Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisTreatment
NCT0109384638 Week Extension Study to CAIN457C2303Treatment